Cemiplimab in AlloSCT/SOT Recipients With CSCC

NCT04339062 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma
Advanced Cancer

Interventions

DRUG: Cemiplimab
DRUG: Everolimus
DRUG: Sirolimus
DRUG: Prednisone

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]